Antimicrobial effects of drugs against multidrug-resistant Pseudomonas aeruginosa

Biological and Pharmaceutical Bulletin

Volumn 31, Issue 10, 2008, Pages 1898-1901

  Maeda, Kumiko ^a   Kobayashi, Youko ^a   Oie, Shigeharu ^a   Ishida, Shiro ^a   Okano, Yoshiro ^a   Kobayashi, Toshihiko ^b   Shikichi, Kyoko ^b   Mizuno, Hidekazu ^b   Kamiya, Akira ^a  

^a YAMAGUCHI UNIVERSITY HOSPITAL   (Japan)

^b TOKUSHIMA BUNRI UNIVERSITY   (Japan)

Author keywords

Amikacin; Aztreonam; Ceftazidime; Combined effect; Multidrug resistant; Pseudomonas aeruginosa

Indexed keywords

AMIKACIN; ANTIINFECTIVE AGENT; AZTREONAM; CEFTAZIDIME; CIPROFLOXACIN; COLISTIN; IMIPENEM; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM;

ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIOSTASIS; COMBINATION CHEMOTHERAPY; DRUG EFFICACY; DRUG INDICATION; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; PSEUDOMONAS AERUGINOSA; STRAIN IDENTIFICATION;

ANTI-BACTERIAL AGENTS; CROSS INFECTION; DNA, BACTERIAL; DRUG COMBINATIONS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; MICROBIAL SENSITIVITY TESTS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 53549120664     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.31.1898     Document Type: Article

References (26)

1. Landman D., Bratu S., Kochar S., Panwar M., Trehan M., Doymaz M., Quale J., J. Antimicrob. Chemother., 60, 78-82 (2007).
2. Karlowsky J. A., Draglii D. C., Jones M. E., Thornsberry C., Friedland I. R., Sahm D. F., Antimicrob. Agents Chemother., 47, 1681-1688 (2003).
3. Rolston K. V., Bodey G. P., Cancer Invest., 10, 43-59 (1992).
4. the NNIS System, Am. J. Infect. Control, 27, 520-532 (1999).
5. Bonfiglio G., Carciotto V., Russo G., Stefani S., Schito G. C., Debbia E., Nicoletti G., J. Antimicrob. Chemother., 41, 307-310 (1998).
6. Livermore D. M., Antimicrobial Resistance, 34, 634-640 (2002).
7. Oie S., Uematsu T., Sawa A., Mizuno H., Tomita M., Ishida S., Okano Y., Kamiya A., J. Antimicrob. Chemother., 52, 911-914 (2003).
8. Oie S., Sawa A., Kamiya A., Mizuno H., J. Antimicrob. Chemother., 44, 689-691 (1999).
9. Nihonyanagi S., Hirata Y., Akabosi T., Uchiyama Y., Yamaura N., Sunakawa K., Inoue M., J. Jpn. Assoc. Infect. Dis., 80, 97-102 (2006).
10. Mahenthiralingam E., Campbell M. E., Foster J., Lam J. S., Speert D. P., J. Clin. Microbiol., 34, 1129-1135 (1996).
11. Barnini S., Dodi C., Campa M., Lett. Appl. Microbiol., 39, 274-277 (2004).
12. National Commitee for Clinical Laboratory Standards, "Methods for Dilution Antimicrbial Susceptibility Tests for Bacteria that Grow Aerobically-Second Edition," Approved Standard M7-A2. NCCLS, Villanova, PA, 1990.
13. Soussy C. J., Cluzel R., Courvalin P. E. J., Clin. Microbiol. Infect. Dis., 13, 238-246 (1994).
14. Rochon-Edouard S., Pestel-Caron M., Lemeland J. F., Caron F., Antimicrob. Agents Chemother., 44, 3055-3060 (2000).
15. Giamarellos-Bourboulis E. J., Grecka P., Giamarellou H., J. Antimicrob. Chemother., 38, 287-291 (1996).
16. Hallander H. O., Dornbusch K., Gezelius L., Jacobson K., Karlsson I., Antimicrob. Agents Chemother., 22, 743-752 (1982).
17. Nakagawa K., Yasuda Y., Nakajima Y., Watanabe Y., Noguchi M., Suzuki T., Jpn. J. Antibiot., 12, 2797-2804 (1982).
18. Matsumoto T., Nagatake T., Oishi K., Amamoto T., Urae R., Irie S., Nii Y., Urae A., J. Infect. Chemother., 42, 281-299 (1994).
19. Ohara K., Yamamoto K., Mogi H., Ito T., Saito M., Ono Y., Nagata K., Kamiya O., Hoshino A., Hirano M., Maruyama F., Ohno R., Adachi K., Kitaori K., Shirakawa S., Minami N., Katayama N., Tanaka M., Kobayashi M., Ikeda Y., Kodera Y., Matsushita T., Mitomo Y., Nitta M., Kodama H., Yamada K., Naito K., J. Infect. Chemother., 37, 1062-1070 (1989).
20. Evans M. E., Feola D. J., Rapp R. P., Ann. Pharmacother., 33, 960-967 (1999).
21. Levin A. S., Barone A. A., Penço J., Santos M. V., Marinho I. S., Arruda E. A., Manrique E. I., Costa S. F., Clin. Infect. Dis., 28, 1008-1011 (1999).
22. Berlana D., Llop J. M., Fort E., Badia M. B., Jódar R., Am. J. Health-Syst. Pharm., 62, 39-47 (2005).
23. Linden P. K., Kusne S., Coley K., Fontes P., Kramer D. J., Paterson D., Clin. Infect. Dis., 37, 154-160 (2003).
24. Markou N., Apostolakos H., Koumoudiou C., Athanasiou M., Koutsoukou A., Alamanos I., Gregorakos L., Crit. Care, 7, 78-83 (2003).
25. Falagas M. E., Kasiakou S. K., Crit. Care, 10, 1-13 (2006).
26. Kallel H., Bahloul M., Hergafi L., Akrout M., Ketata W., Chelly H., Hamida C. B., Rekik N., Hammami A., Bouaziz M., Int. J. Antimicrob. Agents, 28, 366-369 (2006).